ARS Pharmaceuticals, Inc. Class Action Lawsuit - SPRY

Company
ARS Pharmaceuticals, Inc. (NASDAQ: SPRY)
Class Period
March 13, 2023 - September 20, 2023

Never Miss Another Deadline

Choose your preferred way to stay informed of new case launches and settlement deadlines

WhatsApp

Scan the QR code or click the button to join

Join on WhatsApp

Get Updates by Email

Required Field

Required Field

Required Field

No Spam, opt-out anytime, alert list is free

Allegations

The filed complaint alleges that ARS Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that:

Eligibility

In order to be eligible to join the SPRY class action lawsuit, you must have incurred a loss on shares of ARS purchased during the class period listed above.

TOP